Pharmafile Logo
Pharmafocus logo
Advanced Search

guidance

Showing 6 posts of 6 posts found.

nice_new_london_office_internal_2_8

NICE reject Clovis Oncology’s ovarian cancer drug Rubraca

August 6, 2019
Manufacturing and Production NHS, NICE, Rubraca, UK, guidance, pharma

Britain’s cost-effectiveness body NICE has chosen not to recommend Clovis Oncology’s cancer drug Rubraca (rucaparib). On 6 August, NICE issued …

News

NHS guidance suggests mental health therapists should be brought into GP surgeries

August 29, 2018
Research and Development England, GP, NHS, guidance, psychology, psychotherapy

New NHS guidelines will encourage doctors to incorporate mental health therapists into practice surgeries in an effort to bring more …

News

NICE issues new guidance on the safer use of controlled drugs

April 13, 2016
Medical Communications NICE, controlled drugs, guidance

The National Institute for Health and Care Excellence (NICE) has issued guidance bringing together legislation and existing advice on the …

News
novartissunlight_copy

Novartis’s heart failure drug given final recommendation by NICE

March 21, 2016
Manufacturing and Production, Research and Development Entresto, NICE, Novartis, approval, draft, guidance, heart failure, heart failure drug

The National Institute for Health and Care Excellence (NICE) has issued its final guidance on Entresto (sacubritil/valsartan), a heart failure …

News

New NICE guidelines to tackle antibiotic ‘addiction’

August 18, 2015
Manufacturing and Production AMR, Antibiotics, NICE, antimicrobial resistance, guidance, infections

NICE has published guidance to help health care professionals promote and monitor the sensible use of antibiotics – and support …

News
NICE guidance app

NICE launches new guidance app

March 20, 2012
Medical Communications, Sales and Marketing Android, Apple, NICE, app, digital, guidance

NICE has launched a new app that allows mobile access to all of NICE’s recommendations and advice of the past …

News

Latest content

Regeneron and Mammoth Biosciences announce CRISPR collaboration

April 26, 2024

ANGLE signs commercial agreement with AstraZeneca

April 26, 2024

Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement

April 25, 2024

Ascendis Pharma’s Yorvipath approved by MHRA for hypoparathyroidism treatment

April 25, 2024

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024